View Author
strut stent scaffold patient month follow-up vessel analysis lesion study artery change implantation diameter trial 6 months baseline lumen everolimu bioresorbable serruy curvature device imaging angulation everolimus-eluting plaque cohort result coherence tomography 6- month follow-up value abbott angiographic signi tissue recoil figure intervention intravascular segment system serruys pw scaffold area coherence group ultrasound tomography balloon neointimal 12 months sb ori fice angiography vessel wall table difference cardiol image malapposed struts drug-eluting procedure ficant regar e malapposed 12- month follow-up scaffold pattern irregularities reduction swets subs service stenosi xience assessment comparison hyperechogenicity everolimus bvs ivus-vh geometry coverage netherland polymer 1.1
10 Most Recent Publications
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Gomez-Lara, J. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Rapoza, R. Ormiston, J.A. Serruys, P.W.J.C. Garcia-Garcia, H.M. Heo, J.H. Farooq, V. Geuns, R-J.M. van Chevalier, B. Windecker, S. McClean, D. Thuesen, L. |
2011-11-24
|
|
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Hebert, K.M. Sudhir, K. Garcia-Garcia, H.M. Ormiston, J.A. Dudek, D. Smits, P.C. Koolen, J. Chevalier, B. Bruyne, B. de Thuesen, L. McClean, D. Geuns, R-J.M. van |
2011-10-04
|
|
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography
(Article)
Gomez-Lara, J. Radu, M. Whitbourn, R. Dudek, D. Smits, P.C. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Brugaletta, S. Farooq, V. Diletti, R. Onuma, Y. Windecker, S. Thuesen, L. McClean, D. Koolen, J. |
2011-09-01
|
|
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
(Article)
Diletti, R. Onuma, Y. Chevalier, B. McClean, D. Windecker, S. Whitbourn, R. Smits, P.C. Koolen, J. Meredith, I. Li, D. Veldhof, S. Rapoza, R. Farooq, V. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Gomez-Lara, J. Brugaletta, S. Geuns, R-J.M. van Regar, E.S. Bruyne, B. de Dudek, D. Thuesen, L. |
2011-07-12
|
|
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent
(Article)
Onuma, Y. Serruys, P.W.J.C. Windecker, S. Whitbourn, R. Meredith, I. Garcia-Garcia, H.M. Ormiston, J.A. Gomez, J. Bruyne, B. de Dudek, D. Thuesen, L. Smits, P. Chevalier, B. McClean, D. Koolen, J. |
2011-07-01
|
|
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Smits, P.C. Chevalier, B. Morel, M-A.M. Dorange, C. Veldhof, S. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Farooq, V. Geuns, R-J.M. van Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. Koolen, J. |
2011-07-01
|
|
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Koolen, J. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Miquel-Hébert, K. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruyne, B. de Regar, E.S. Dudek, D. Thuesen, L. Smits, P.C. Chevalier, B. McClean, D. |
2010-11-30
|
|
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents
(Article)
Gomez-Lara, J. Garcia-Garcia, H.M. Koolen, J. Whitbourn, R. Smits, P.C. Chevalier, B. Dorange, C. Veldhof, S. Morel, M-A.M. Vries, T. de Ormiston, J.A. Serruys, P.W.J.C. Onuma, Y. Garg, S.A. Regar, E.S. Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. |
2010-11-01
|
